We will be present at the 10th LSX World Congress in London, United Kingdom, from April 29-30th.
We are excited to be at this conference once again, which brings together life science executives and leaders from the world’s most pioneering BioTech, MedTech and HealthTech companies.
Our CEO and Co-Founder, Vanessa Vankerckhoven, will be part of panel discussion on Apr 30, 2024, 14u40-15u20 (UK Time). Additionally, our CTO and Co-Founder, Koen Beyers, alongside Vanessa will engage in the Partnering to actively connect with the investor community in MedTech.
Connect with them during the session to learn more about how skin is an optimal site for drug delivery and vaccination and how our solution, VAX-ID could be a game-changer in this space.
Interested in our solutions?
Contact our commercial team!